Hea ki te hoko Velpatasvir (Epclusa)? Velpatasvir (Velpanat, Velasof): te utu i roto i Russia

"Velpatasvir» (velpatasvir) - ko te tarukino hou whakawhanakehia e Kireara Inc. Kei te whakamahia te reira i roto i te maimoatanga o te kakā C. He tikanga tino whai hua te tahuri ki te 2 me te tohuira 3 HCV. Na rite te roa rite rongoa ki a ia i roto i te kaha ki te kahore.

tikanga Pahekotanga sofosbuvir (400 mg) velpatasvirom (100 mg) te ki te aro i tetahi C huaketo tohuira kakā me homai 100% hua, ara, ki te kahore i angitu te therapy whakahaere i mua. I whakawhanakehia te reira i roto i te United States, farmgigantom Kireara Inc, a he wātea i roto i te puka papa, e mau ana i te ingoa "Epklusa".

Sofosbuvir i roto i tenei faaineineraa inhibits RNA polymerase, me i te kape huaketo tona RNA me velpatasvir pānga te polymerase NS5B, te kupu haukotia te whakataki o te huinga ira viral i roto i ngā pūtau noa.

Hea ki te hoko velpatasvir me te sofosbuvir i roto i te faaineineraa ngā?

Hokona pire "Epklusa" tino uaua, rite he ratou neke atu i te 60 000 euros mo te akoranga e toru-marama o te maimoatanga, i, kia rite ki matau koutou, mo te nuinga o tūroro nui noa e taea te kore e utu. Aua'e, i roto i te 2017 kua homai te kamupene Kireara kamupene Indian Hetero NATCO Pharma me raihana kore-motuhake ki te whakaputa uri arowhānui raihana: VELPANAT (NATCO) me VELASOF (HETERO). Hokona velpatasvir + sofosbuvir inaianei taea i roto i India i te utu tika.

Whakaora hoki tūroro maha te huinga - sofosbuvir + velpatasvir - Ka taea te hokona online nui whatunga distribyutorskoy WWW.HCV24.COM Indian.

Ki te tono ipurangi Epclusa kamupene Indian kano, e hiahia ana koe ki te whai tuhinga ata mohiotia e c hiahia tino koe te maimoatanga o te kakā.

Na e kore tūroro e whai feaa, kia mea tatou e te kano - ko reira he orotahi tūturu raau parani, whakaputaina nei e te hangarau kua whakawhanakehia, a na reira e kore e ngā te utu o te haamau'araa i runga i whakatairanga rangahau me te mākete. Ko tenei, nui atu i te kounga iti, pera whakaaro etahi, he nui atu te utu atu i te tikanga waitohu arowhānui.

contraindications

Ka rite ki a koutou e taea te kite, te tikanga-he mahuinga i roto i te whawhai ki te mate nui. Ko te aroaro te hoko koe "Velpatasvir" ranei tona i ngā ki sofosbuvir, kia mohio koutou e whakamahi wahine te tarukino i roto i te hapū, me te ū, me te tangata, i roto i te take o te hoa hapūtanga, e kore e tohunga tūtohu.

Kaua e whakahau tenei taputapu me ngā tūroro i raro i te tau o te 18 tau, me te ki ātete takitahi ki ngā wae tarukino.

Ki te tupato whakamahi reira i roto i te maimoatanga o te tūroro pakeke atu i te 65 tau, me te te mamae i kino iti hoki tākihi.

dosing

Drug "Epklusa", me te tona kano (sofosbuvir velpatasvir +), tangohia te utu me ngā tikanga o te tono e kōrerohia i roto i tēnei tuhinga, kotahi te ra kotahi papa. te tikanga pumau te akoranga o te maimoatanga mō te toru marama.

I roto i te aroaro o te cirrhosis decompensated (piha B me te C) tūtohutia te manawanui e ki whakawhānui i te akoranga ki te 24 wiki. A i roto i tenei take, kawea maimoatanga i roto i roto i ngā ki te faaineineraa o "ribavirin".

pānga taha

I mua hoko koe "Velpatasvir" pahekotanga ranei, a kia mohio koutou e pā ana ki te pānga taha e kia puta i roto i te whakamahi. Ko te kupu, kia wheako tūroro:

• whanoke;
• disorders o whakarongo me te mahara;
• kaihapai;
• hāhā o te manawa;
• korere;
• anemia;
• edema piringa;
• hypothyroidism;
• ponana;
• mate pāwera;
• photosensitivity.

Kēhi o tarukino tuwhena rawa "Velpatasvir", ka taea e koe te hoko e i te pae whakaarohia, kihai i rite.